Skip to main content
. 2015 Feb 19;36(5):1637–1647. doi: 10.1002/hbm.22722

Table 1.

Clinical variables according to outcome

Variable Seizure free (n = 47) Persistent seizures (n = 40) Confirmatory statistics
Female/male 21/26 26/14 χ 2 = 2.82, P = 0.10
Age at MRI 39.4 (12.6) 39.5 (14.3) F = 0.002, P = 0.97
Age at onset of mTLE 16.8 (11.8) 15.3 (12.4) F = 0.33, P = 0.57
Presurgical duration of mTLE 20.5 (12.9) 26.2 (16.1) F = 2.25, P = 0.13
Febrile convulsions 14 (29.8%) 15 (37.5%) χ 2 = 0.28, P = 0.59
Meningitis 6 (12.8%) 5 (12.5%) χ 2 = 0.001, P = 0.97
Seizure frequency 6.6 (10.7) 8.1 (14.6) F = 0.31, P = 0.58
SGTCS 12 (25.5%) 21 (52.5%) χ 2 = 5.58, P = 0.02*
Age at surgery 39.6 (12.5) 39.9 (14.3) F = 0.01, P = 0.91
Side of surgery (L/R) 30/19 25/13 χ 2 = 0.05, P = 0.83
Follow up 22.8 (8.2) 23.7 (9.8) F = 0.33, P = 0.72

Age at MRI, age at onset, duration of mTLE, and age at surgery are years. Follow up is months. Sex, febrile convulsions, meningitis, and side of surgery are number of cases. Seizure frequency is number per month. Abbreviations: SGTCS, secondary generalized tonic‐clonic seizures.